Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a research report sent to investors on Friday. The brokerage issued a hold rating on the stock.

Separately, Cantor Fitzgerald reissued a neutral rating and set a $3.30 target price on shares of Aspira Women’s Health in a report on Wednesday, April 10th.

Aspira Women’s Health Price Performance

Shares of Aspira Women’s Health stock opened at $3.21 on Friday. The firm has a fifty day moving average price of $3.44 and a 200 day moving average price of $3.91. Aspira Women’s Health has a 1 year low of $2.31 and a 1 year high of $6.75. The stock has a market cap of $39.62 million, a PE ratio of -0.27 and a beta of 1.57.

Aspira Women’s Health (NASDAQ:AWH) last issued its earnings results on Thursday, March 28th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.39) by $0.09. Aspira Women’s Health had a negative net margin of 176.74% and a negative return on equity of 1,099.32%. The firm had revenue of $2.13 million during the quarter, compared to analysts’ expectations of $2.70 million. As a group, equities analysts expect that Aspira Women’s Health will post -1.24 EPS for the current year.

Institutional Trading of Aspira Women’s Health

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Northeast Financial Consultants Inc acquired a new position in Aspira Women’s Health during the third quarter worth about $126,000. Quantum Private Wealth LLC boosted its position in Aspira Women’s Health by 76.8% during the fourth quarter. Quantum Private Wealth LLC now owns 50,156 shares of the company’s stock worth $205,000 after acquiring an additional 21,788 shares during the last quarter. Perkins Capital Management Inc. acquired a new position in Aspira Women’s Health during the third quarter worth about $268,000. Finally, B. Riley Wealth Advisors Inc. boosted its position in Aspira Women’s Health by 39.0% during the third quarter. B. Riley Wealth Advisors Inc. now owns 125,374 shares of the company’s stock worth $672,000 after acquiring an additional 35,177 shares during the last quarter. Hedge funds and other institutional investors own 12.19% of the company’s stock.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.